slides · global inventory
Comparison Frame
Framework collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 6,294
Current window 4,891-4,920
Pages 210
Rows per page 30
Framework
4,891-4,920 of 6,294
05
Uses a visual comparison between small molecule data availability and biologic data scarcity.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Why nowLoop · Cost Of Inaction1 hit
04
Uses a two-column comparison for Sepsis vs Septic Shock, followed by two rows of key metrics.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The slide highlights the superior NPV of IL-6 compared to standard biomarkers using a table and an ROC curve.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
The table uses green checkmarks for Comera and grey checkmarks for competitors, highlighting Comera's unique combination of all three advantages.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Golden Circle1 hit
21
The slide uses a split-panel layout to contrast current capabilities with future advancements.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
15
The slide uses a visual comparison framework to illustrate the mechanism of action and therapeutic benefits.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
19
The slide uses Western blot data to visually demonstrate the efficacy of EQ101 compared to a standard JAK inhibitor.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
20
Includes before/after patient photos and comparative data against Mogamulizumab.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
24
The slide compares two different drugs (baricitinib and deuruxolitinib) using their respective clinical trial data (BRAVE AA1 and THRIVE AA1).Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations 1 hit
15
The slide uses a cross-trial comparison to highlight the efficacy of Olvi-Vec in heavily pre-treated patients.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · Market Size1 hit
08
The slide uses a structural diagram to highlight the substitution of the 'Tumor Binding Domain' with the 'COBRA Binder' in the NXC-201 molecule.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Problem & Complication1 hit
14
The slide explicitly notes that these are not head-to-head results and caution should be exercised in comparison.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Problem & Complication1 hit
17
The slide uses a visual timeline comparison to highlight the clinical advantage of NXC-201's shorter side-effect profile.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & Proof1 hit
23
The slide explicitly notes that these are cross-trial comparisons and not head-to-head results.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
31
The slide uses a red dashed box to highlight the primary efficacy metrics for comparison.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · David Goliath1 hit
33
The chart uses a grouped bar structure to compare NXC-201 (green) against other therapies (blue/red/grey).Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · David Goliath1 hit
45
The slide highlights that NXC-201 has no exclusion for prior BCMA therapy, unlike the other listed treatments.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
57
The slide compares efficacy benchmarks of established competitors (AbbVie, J&J, Takeda) to set a baseline for the IMX-120 opportunity.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
39
Uses a stacked bar chart to visualize the 'dollar gap' between ad spend allocation and consumer time spent.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
41
The slide uses arrows to indicate that traditionally SVOD platforms are expanding into AVOD offerings.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Beat · Market Size1 hit
48
The slide uses a comparison structure to link client needs (RFP drivers) to the vendor's value proposition (Why We Won).Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 1 hit
15
The slide includes a disclaimer that the comparison is not head-to-head and uses historical benchmarks.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
90
The slide uses a comparison table to demonstrate the rapid growth of AI-related metrics over a six-year period.SoftBank | Results Presentation Deck | 100 slides · SoftBank
Conference presentation Investor relations Beat · VisualizationLoop · Golden Circle1 hit
22
The slide uses a comparison table to demonstrate the rapid growth of AI-related metrics over a six-year period.SoftBank | Results Presentation Deck | 32 slides · SoftBank
Conference presentation Investor relations Beat · DevelopmentLoop · Cost Of Inaction1 hit
06
The slide uses a stacked bar chart format to compare investment vs return, highlighting equity value and borrowings.SoftBank | Results Presentation Deck | 72 slides · SoftBank
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
44
The slide uses a comparison frame to distinguish between two investment vehicles within the same organization.SoftBank | Results Presentation Deck | 72 slides · SoftBank
Conference presentation Investor relations Beat · Action1 hit
18
The chart uses a baseline to show negative growth for several major hotel chains.Sonder | Investor Presentation Deck | 27 slides · Sonder
Pitch deck Investor relations Beat · Financials1 hit
07
The slide uses a comparative structure to validate market leadership through specific product rankings.Sonos | Investor Presentation Deck | 21 slides · Sonos
Pitch deck Investor relations Beat · Rising Success1 hit
15
The slide uses a checkmark matrix to validate the strategic fit of two specific M&A targets.Vivid Seats | Investor Presentation Deck | 24 slides · Vivid Seats
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
08
The slide uses a checkmark matrix to validate the strategic rationale for two specific M&A deals.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations Loop · Cost Of Inaction1 hit